miRNA-183 Suppresses Apoptosis and Promotes Proliferation in Esophageal Cancer by Targeting PDCD4 |
Yang, Miao
(Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University)
Liu, Ran (Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University) Li, Xiajun (Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University) Liao, Juan (Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University) Pu, Yuepu (Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University) Pan, Enchun (Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University) Yin, Lihong (Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University) Wang, Yi (Huaian Center for Disease Control and Prevention) |
1 | Zhang, S.H., Li, J.F., Jiang, Y., Xu, Y.J., and Qin, C.Y. (2009). Programmed cell death 4 (PDCD4) suppresses metastastic potential of human hepatocellular carcinoma cells. J. Exp. Clin. Cancer Res. 28, 71. DOI ScienceOn |
2 | Zhang, X., Wang, X.Y., Song, X.G., Liu, C.M., Shi, Y.Y., Wang, Y.K., Afonja, O., Ma, C.H., Chen, Y.H.H., and Zhang, L.N. (2010). Programmed cell death 4 enhances chemosensitivity of ovarian cancer cells by activating death receptor pathway in vitro and in vivo. Cancer Sci. 101, 2163-2170. DOI ScienceOn |
3 | Zhao, H.E., Guo, M.J., Zhao, G.Y., Ma, Q., Ma, B.A., Qiu, X.C., and Fan, Q.Y. (2012). miR-183 inhibits the metastasis of osteosarcoma via downregulation of the expression of Ezrin in F5M2 cells. Int. J. Mol. Med. 30, 1013-1020. DOI |
4 | Zhu, J.F., Feng, Y.P., Ke, Z.F., Yang, Z., Zhou, J.Y., Huang, X.R., and Wang, L.T. (2012). Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin. Am. J. Pathol. 180, 2440-2451. DOI ScienceOn |
5 | Shibahara, K., Asano, M., Ishida, Y., Aoki, T., Koike, T., and Honjo, T. (1995). Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death. Gene 166, 297-301. DOI ScienceOn |
6 | Tanaka, H., Sasayama, T., Tanaka, K., Nakamizo, S., Nishihara, M., Mizukawa, K., Kohta, M., Koyama, J., Miyake, S., Taniguchi, M., et al. (2013). MicroRNA-183 upregulates HIF-1alpha by targeting isocitrate dehydrogenase 2 (IDH2) in glioma cells. J. Neuro-Oncol. 111, 273-283. DOI ScienceOn |
7 | Wei, N., Liu, S.S., Chan, K.K.L., and Ngan, H.Y.S. (2012). Tumour suppressive function and modulation of programmed Cell Death 4 (PDCD4) in ovarian cancer. PLoS One 7, e30311 . DOI |
8 | Thomson, D.W., Bracken, C.P., and Goodall, G.J. (2011). Experimental strategies for microRNA target identification. Nucleic Acids Res. 39, 6845-6853. DOI ScienceOn |
9 | Ueno, K., Hirata, H., Shahryari, V., Deng, G., Tanaka, Y., Tabatabai, Z.L., Hinoda, Y., and Dahiya, R. (2013). microRNA-183 is an oncogene targeting Dkk-3 and SMAD4 in prostate cancer. Br. J. Cancer 108, 1659-1667. DOI ScienceOn |
10 | Wang, W., Zhao, J., Wang, H., Sun, Y., Peng, Z., Zhou, G., Fan, L., Wang, X., Yang, S., Wang, R., et al. (2010). Programmed cell death 4 (PDCD4) mediates the sensitivity of gastric cancer cells to TRAIL-induced apoptosis by down-regulation of FLIP expression. Exp. Cell Res. 316, 2456-2464. DOI ScienceOn |
11 | Yang, M., Liu, R., Sheng, J.Y., Liao, J., Wang, Y., Pan, E.C., Guo, W., Pu, Y.P., and Yin, L.H. (2013). Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of esophageal squamous cell carcinoma. Oncol. Rep. 29, 169-176. DOI |
12 | Zhang, H., OzakiZ, I., Mizuta, T., Hamajima, H., Yasutake, T., Eguchi, Y., Ideguchi, H., Yamamoto, K., and Matsuhashi, S. (2006). Involvement of programmed cell death 4 in transforming growth factor-beta 1-induced apoptosis in human hepatocellular carcinoma. Oncogene 25, 6101-6112. DOI ScienceOn |
13 | Lin, Y., Totsuka, Y., He, Y., Kikuchi, S., Qiao, Y., Ueda, J., Wei, W., Inoue, M., and Tanaka, H. (2013). Epidemiology of esophageal cancer in Japan and China. J. Epidemiol. 23, 233-242. DOI |
14 | Patil, V.S., Zhou, R., and Rana, T.M. (2014). Gene regulation by non-coding RNAs. Crit. Rev. Biochem. Mol. Biol. 49, 16-32. DOI ScienceOn |
15 | Livak, K.J., and Schmittgen, T.D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2- method. Methods 25, 402-408. DOI ScienceOn |
16 | Ma, G., Zhang, H., Dong, M., Zheng, X.Y., Ozaki, I., Matsuhashi, S., and Guo, K.J. (2013). Downregulation of programmed cell death 4 (PDCD4) in tumorigenesis and progression of human digestive tract cancers. Tumor Biol. 34, 3879-3885. DOI ScienceOn |
17 | Matsuhashi, S., Hamajima, H., Xia, J.H., Zhang, H., Mizuta, T., Anzai, K., and Ozaki, I. (2014). Control of a tumor suppressor PDCD4: Degradation mechanisms of the protein in hepatocellular carcinoma cells. Cell. Signal. 26, 603-610. DOI ScienceOn |
18 | Sarver, A.L., Li, L.H., and Subramanian, S. (2010). MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration. Cancer Res. 70, 9570-9580. DOI |
19 | Reis, P.P., Tomenson, M., Cervigne, N.K., Machado, J., Jurisica, I., Pintilie, M., Sukhai, M.A., Perez-Ordonez, B., Grenman, R., Gilbert, R.W., et al. (2010). Programmed cell death 4 loss increases tumor cell invasion and is regulated by miR-21 in oral squamous cell carcinoma. Mol. Cancer 9, 238. DOI ScienceOn |
20 | Salic, A., and Mitchison, T.J. (2008). A chemical method for fast and sensitive detection of DNA synthesis in vivo. Proc. Natl. Acad. Sci. USA 105, 2415-2420. DOI ScienceOn |
21 | Santhanam, A.N., Baker, A.R., Hegamyer, G., Kirschmann, D.A., and Colburn, N.H. (2010). Pdcd4 repression of lysyl oxidase inhibits hypoxia-induced breast cancer cell invasion. Oncogene 29, 3921-3932. DOI ScienceOn |
22 | Hvid-Jensen, F., Pedersen, L., Drewes, A.M., Sorensen, H.T., and Funch-Jensen, P. (2011). Incidence of adenocarcinoma among patients with Barrett's esophagus. N. Engl. J. Med. 365, 1375-1383. DOI ScienceOn |
23 | Guo, P., Huang, Z.L., Yu, P., and Li, K. (2012). Trends in cancer mortality in China: an update. Ann. Oncol. 23, 2755-2762. DOI ScienceOn |
24 | He, J., and Chen, W. (2012). Chinese Cancer Registry Annual Report (Beijing, China: Military Medical Sciences Press). |
25 | Hu, Y., Correa, A.M., Hoque, A., Guan, B., Ye, F., Huang, J., Swisher, S.G., Wu, T.T., Ajani, J.A., and Xu, X.C. (2011). Prognostic significance of differentially expressed miRNAs in esophageal cancer. Int. J. Cancer 128, 132-143. DOI ScienceOn |
26 | Jiang, Y., Zhang, S.H., Han, G.Q., and Qin, C.Y. (2010). Interaction of Pdcd4 with eIF4E inhibits the metastatic potential of hepatocellular carcinoma. Biomed. Pharmacother. 64, 424-429. DOI ScienceOn |
27 | Koo, S.H., Ihm, C.H., Kwon, K.C., Park, J.W., Kim, J.M., and Kong, G. (2001). Genetic alterations in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Cancer Genet. Cytogenet. 130, 22-28. DOI ScienceOn |
28 | Kwong, D., Lam, A., Guan, X., Law, S., Tai, A., Wong, J., and Sham, J. (2004). Chromosomal aberrations in esophageal squamous cell carcinoma among Chinese: Gain of 12p predicts poor prognosis after surgery. Hum. Pathol. 35, 309-316. DOI ScienceOn |
29 | Lankat-Buttgereit, B., and Goke, R. (2009). The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation. Biol. Cell 101, 309-317. DOI ScienceOn |
30 | Li, G.R., Luna, C., Qiu, J.M., Epstein, D.L., and Gonzalez, P. (2010a). Targeting of integrin and kinesin by microRNA 183. J. Biol. Chem. 285, 5461-5471. DOI ScienceOn |
31 | Fassan, M., Cagol, M., Pennelli, G., Rizzetto, C., Giacomelli, L., Battaglia, G., Zaninotto, G., Ancona, E., Ruol, A., and Rugge, M. (2010). Programmed cell death 4 protein in esophageal cancer. Oncol. Rep. 24, 135-139. |
32 | Corcoran, M.M., Mould, S.J., Orchard, J.A., Ibbotson, R.E., Chapman, R.M., Boright, A.P., Platt, C., Tsui, L.C., Scherer, S.W., and Oscier, D.G. (1999). Dysregulation of cyclin dependent kinase 6 expression in splenic marginal zone lymphoma through chromosome 7q translocations. Oncogene 18, 6271-6277. DOI ScienceOn |
33 | Dubecz, A., Gall, I., Solymosi, N., Schweigert, M., Peters, J.H., Feith, M., and Stein, H.J. (2012). Temporal trends in long-term survival and cure rates in esophageal cancer: a seer database analysis. J. Thorac. Oncol. 7, 443-447. DOI ScienceOn |
34 | Fang, L., Du, W.W., Yang, W.N., Rutnam, Z.J., Peng, C., Li, H.R., O'Malley, Y.Q., Askeland, R.W., Sugg, S., Liu, M.Y., et al. (2012). MiR-93 enhances angiogenesis and metastasis by targeting LATS2. Cell Cycle 11, 4352-4365. DOI ScienceOn |
35 | Frankel, L.B., Christoffersen, N.R., Jacobsen, A., Lindow, M., Krogh, A., and Lund, A.H. (2008). Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J. Biol. Chem. 283, 1026-1033. DOI ScienceOn |
36 | Han, Y., Chen, J., Zhao, X., Liang, C., Wang, Y., Sun, L., Jiang, Z., Zhang, Z., Yang, R., Li, Z., et al. (2011). MicroRNA expression signatures of bladder cancer revealed by deep sequencing. PLoS One 6, e18286. DOI ScienceOn |
37 | Gaur, A.B., Holbeck, S.L., Colburn, N.H., and Israel, M.A. (2011). Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivo. Neuro Oncol. 13, 580-590. DOI |
38 | Bieche, I., Champeme, M.H., Matifas, F., Hacene, K., Callahan, R., and Lidereau, R. (1992). Loss of heterozygosity on chromosome 7q and aggressive primary breast cancer. Lancet 339, 139-143. DOI ScienceOn |
39 | Guo, X., Li, W., Wang, Q., and Yang, H.S. (2011). AKT activation by Pdcd4 knockdown up-regulates cyclin D1 expression and promotes cell proliferation. Genes Cancer 2, 818-828. DOI ScienceOn |
40 | Achille, A., Biasi, M.O., Zamboni, G., Bogina, G., Magalini, A.R., Pederzoli, P., Perucho, M., and Scarpa, A. (1996). Chromosome 7q allelic losses in pancreatic carcinoma. Cancer Res. 56, 3808-3813. |
41 | Borel, C., and Antonarakis, S.E. (2008). Functional genetic variation of human miRNAs and phenotypic consequences. Mamm. Genome 19, 503-509. DOI |
42 | Fassan, M., Realdon, S., Pizzi, M., Balistreri, M., Battaglia, G., Zaninotto, G., Ancona, E., and Rugge, M. (2012). Programmed cell death 4 nuclear loss and miR-21 or activated Akt overexpression in esophageal squamous cell carcinogenesis. Dis. Esophagus 25, 263-268. DOI ScienceOn |
43 | Eto, K., Goto, S., Nakashima, W., Ura, Y., and Abe, S.I. (2012). Loss of programmed cell death 4 induces apoptosis by promoting the translation of procaspase-3 mRNA. Cell Death Differ. 19, 573-581. DOI |
44 | Calin, G.A., and Croce, C.M. (2006). MicroRNA signatures in human cancers. Nat. Rev. Cancer 6, 857-866. DOI ScienceOn |
45 | Li, J., Fu, H., Xu, C., Tie, Y., Xing, R., Zhu, J., Qin, Y., Sun, Z., and Zheng, X. (2010b). miR-183 inhibits TGF-beta1-induced apoptosis by downregulation of PDCD4 expression in human hepatocellular carcinoma cells. BMC Cancer 10, 354. DOI ScienceOn |